May 24 (Reuters) - Regeneus Ltd (RGS) Announces Japanese patent office decision to grant key patent for Progenza stem cell technology Progenza for treatment of osteoarthritis and other inflammatory conditions for human and animal applications
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
